Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2025-12-24 @ 9:44 PM
NCT ID:
NCT00535132
Eligibility Criteria:
Inclusion Criteria:
* Must be able to understand, in the opinion of the investigator, the informed consent form.
* be diagnosed with schizophrenia
* report dissatisfaction with current medication
* have an aspect of schizophrenia management which could potentially benefit from a change in antipsychotic medication
* receive risperidone 4 mg or 6 mg for at least 4 weeks before the start of the study.
Exclusion Criteria:
* Unable to swallow study drug whole with the aid of water
* cannot have received an investigational drug, used an investigational medical device, or participated in a clinical study that altered their medication within 6 months before the first administration of study drug, or have participated in more than 2 investigational drug studies within the past 12 months
* no other major mental health diagnosis except for tobacco dependance
* no use of cocaine or heroin within 3 months before the first administration
* no history of treatment with any antipsychotic in addition to treatment with risperidone, or treatment with paliperidone, within 30 days before the baseline visit.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00535132
Study Brief:
Protocol Section:
NCT00535132